Evidence map›Paper›PMID 27152754›Full record

ArticleThe European journal of neuroscience2016

Thalamic amplification of sensory input in experimental diabetes.

Oliver J Freeman, Mathew H Evans, Garth J S Cooper, Rasmus S Petersen, Natalie J Gardiner

Open access · hybridAbstract read
In one paragraph

Article in The European journal of neuroscience, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Oliver J FreemanFaculty of Life Sciences, University of Manchester, Oxford Road, Manchester, M13 9PT, UK.ORCID 0000-0003-4009-282X
Mathew H EvansFaculty of Life Sciences, University of Manchester, Oxford Road, Manchester, M13 9PT, UK.
Garth J S CooperCentre for Advanced Discovery and Experimental Therapeutics (CADET), Central Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Sciences Centre, Manchester, UK.
Rasmus S PetersenFaculty of Life Sciences, University of Manchester, Oxford Road, Manchester, M13 9PT, UK.
Natalie J GardinerFaculty of Life Sciences, University of Manchester, Oxford Road, Manchester, M13 9PT, UK.ORCID 0000-0001-8287-1181
University of Manchester · GBUniversity of Auckland · NZ

Funding

Biotechnology and Biological Sciences Research Council BB/L007282/1Medical Research Council G1001609/MR/J500410/1Medical Research Council MR/L01064X/1
6 · The paper itself

Abstract

Diabetic neuropathy is a common, and often debilitating, secondary complication of diabetes mellitus. As pain, hypersensitivity and paraesthesias present in a distal-proximal distribution, symptoms are generally believed to originate from damaged afferents within the peripheral nervous system. Increasing evidence suggests altered processing within the central nervous system in diabetic neuropathy contributes towards somatosensory dysfunction, but whether the accurate coding and relay of peripherally encoded information through the central nervous system is altered in diabetes is not understood. Here, we applied the strengths of the rodent whisker-barrel system to study primary afferent-thalamic processing in diabetic neuropathy. We found that neurons in the thalamic ventral posteromedial nucleus from rats with experimental diabetic neuropathy showed increased firing to precisely graded, multidirectional whisker deflection compared to non-diabetic rats. This thalamic hyperactivity occurred without any overt primary afferent dysfunction, as recordings from the trigeminal ganglion showed these primary afferents to be unaffected by diabetes. These findings suggest that central amplification can substantially transform ascending sensory input in diabetes, even in the absence of a barrage of ectopic primary afferent activity.

Indexed as

Action PotentialsAnimalsDiabetes Mellitus, ExperimentalDiabetic NeuropathiesMaleNeurons, AfferentRatsRats, Sprague-DawleyThalamic NucleiVibrissaeneuropathyratsomatosensorystreptozotocinthalamus

Identifiers

PMID27152754
PMCPMC4950294
OpenAlexW2346566887

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.